EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

COVID-19 pandemic and antimicrobial resistance in developing countries

Abdul Rehman Arshad, Farhat Ijaz, Mishal Shan Siddiqui, Saad Khalid, Abeer Fatima, Rana Khurram Aftab

Discoveries · 30.06.2021 · 9 (2) · e127

DOI: 10.15190/d.2021.6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discoveries, online erschienen am 30.06.2021. Verfasst von Abdul Rehman Arshad und 5 weiteren Autor:innen. Beteiligte Einrichtung: CMH Lahore Medical College and Institute of Dentistry, Abdur Rehman Road, Cantt, Lahore, Pakistan. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A wide range of antimicrobial agents were touted as potential remedies during the COVID-19 pandemic. While both developed and developing countries have recorded an increase in the use of antimicrobial drugs, use and misuse have occurred to a far greater degree in developing countries. This can have deleterious consequences on antimicrobial resistance, especially when various developing countries have already reported the emergence of various drug-resistant organisms even before the pandemic. Telemedicine services, societal and cultural pressures, and bacterial co-infections can predispose to overwhelming antimicrobial prescriptions. The emergence of new multidrug resistance species is a major concern for the developing world especially since health services are already overburdened and lack the diagnostic capabilities and basic amenities for infection prevention and control. This can lead to outbreaks and the rampant spread of such microorganisms. Improper waste management and disposal from hospitals and communities establish freshwater runoffs as hubs of various microorganisms that can predispose to the rise of multidrug-resistant species. Microplastics' ability to act as vectors for antibioticresistant organisms is also particularly concerning for lower-middle-income countries. In this review, we aim to study the impact of antimicrobial use during the COVID-19 pandemic and antimicrobial resistance in lower middle-income countries, by understanding various determinants of resistance unique to the developing world and exploring solutions to combat the problem.

Schlagwörter

Stichwörter der Autor:innen

COVID-19antibiotic resistant bacteria.antimicrobial resistancedeveloping countries

Autor:innen und Institutionen

  • CMH Lahore Medical College and Institute of Dentistry, Abdur Rehman Road, Cantt, Lahore, Pakistan.
  • Dow Medical College, Dow University of Health Sciences, Mission Road, New Labour Colony Nankwara, Karachi, Pakistan.
  • Punjab Institute of Cardiology, Lahore, Pakistan.

Zitieren

APA

Arshad, A. R., Ijaz, F., Siddiqui, M. S., Khalid, S., Fatima, A., & Aftab, R. K. (2021). COVID-19 pandemic and antimicrobial resistance in developing countries. Discoveries, 9(2), e127. https://doi.org/10.15190/d.2021.6

Vancouver

Arshad AR, Ijaz F, Siddiqui MS, Khalid S, Fatima A, Aftab RK. COVID-19 pandemic and antimicrobial resistance in developing countries. Discoveries. 2021;9(2):e127. doi:10.15190/d.2021.6

BibTeX
@article{Arshad2021,
  author = {Arshad, Abdul Rehman and Ijaz, Farhat and Siddiqui, Mishal Shan and Khalid, Saad and Fatima, Abeer and Aftab, Rana Khurram},
  title = {COVID-19 pandemic and antimicrobial resistance in developing countries},
  journal = {Discoveries},
  year = {2021},
  volume = {9},
  number = {2},
  pages = {e127},
  doi = {10.15190/d.2021.6}
}
Kostenlos starten →